Trial Outcomes & Findings for Efficacy Study of an Unloading Brace for Knee Osteoarthritis (NCT NCT02150057)

NCT ID: NCT02150057

Last Updated: 2019-10-22

Results Overview

The Knee injury and Osteoarthritis Outcome Score (KOOS) questionnaire will be administered to collect patient reported outcomes as they relate to pain, function, and quality of life. The pain scale range is 0-10 with lower scores indicating less pain.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

51 participants

Primary outcome timeframe

Baseline, 6 month follow-up

Results posted on

2019-10-22

Participant Flow

Participant milestones

Participant milestones
Measure
Control Group
This group receives no experimental bracing intervention in the study.
Experimental Group
Breg Fusion Osteoarthritis knee unloading brace Fusion Osteoarthritis Knee Brace: This group is assigned to wear an unloading brace and report pain and quality of life by completion of a pain diary and related questionnaires.
Overall Study
STARTED
25
26
Overall Study
COMPLETED
19
22
Overall Study
NOT COMPLETED
6
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Control Group
This group receives no experimental bracing intervention in the study.
Experimental Group
Breg Fusion Osteoarthritis knee unloading brace Fusion Osteoarthritis Knee Brace: This group is assigned to wear an unloading brace and report pain and quality of life by completion of a pain diary and related questionnaires.
Overall Study
Lost to Follow-up
6
4

Baseline Characteristics

Efficacy Study of an Unloading Brace for Knee Osteoarthritis

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control Group
n=19 Participants
This group receives no experimental bracing intervention in the study.
Experimental Group
n=22 Participants
This group is assigned to wear the BREG Fusion Osteoarthritis Unloading Brace and report pain and quality of life by completion of a pain diary and related questionnaires.
Total
n=41 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
11 Participants
n=5 Participants
11 Participants
n=7 Participants
22 Participants
n=5 Participants
Age, Categorical
>=65 years
8 Participants
n=5 Participants
11 Participants
n=7 Participants
19 Participants
n=5 Participants
Age, Continuous
64.13 years
STANDARD_DEVIATION 6.11 • n=5 Participants
67.8 years
STANDARD_DEVIATION 9.68 • n=7 Participants
65.9 years
STANDARD_DEVIATION 8.12 • n=5 Participants
Sex: Female, Male
Female
8 Participants
n=5 Participants
7 Participants
n=7 Participants
15 Participants
n=5 Participants
Sex: Female, Male
Male
11 Participants
n=5 Participants
15 Participants
n=7 Participants
26 Participants
n=5 Participants
Region of Enrollment
United States
19 participants
n=5 Participants
22 participants
n=7 Participants
41 participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline, 6 month follow-up

Population: Only 19 patients in the control group completed the study. Only 22 patients in the experimental group completed the study.

The Knee injury and Osteoarthritis Outcome Score (KOOS) questionnaire will be administered to collect patient reported outcomes as they relate to pain, function, and quality of life. The pain scale range is 0-10 with lower scores indicating less pain.

Outcome measures

Outcome measures
Measure
Control Group
n=19 Participants
This group receives no experimental bracing intervention in the study.
Experimental Group
n=22 Participants
This group will receive the BREG Fusion Osteoarthritis Knee Unloading Brace to wear for a determined amount of time per study protocol for the treatment of osteoarthritis pain. BREG Fusion Unloading Brace: This group is assigned to wear an unloading brace and report pain and quality of life by completion of a pain diary and related questionnaires.
Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain Score
Baseline Visit
2.92 units on a scale
Standard Deviation 0.57
2.86 units on a scale
Standard Deviation 0.52
Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain Score
6 Month Visit
3.03 units on a scale
Standard Deviation 0.65
2.67 units on a scale
Standard Deviation 0.76

Adverse Events

Control Group

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

Experimental Group

Serious events: 2 serious events
Other events: 3 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Control Group
n=19 participants at risk
This group receives no experimental bracing intervention in the study.
Experimental Group
n=22 participants at risk
Breg Fusion Osteoarthritis knee unloading brace Fusion OA Knee Brace: This group is assigned to wear an unloading brace and report pain and quality of life by completion of a pain diary and related questionnaires.
Cardiac disorders
SOB/A-Fib
0.00%
0/19 • Patients were monitored for adverse events for the 6 month duration that they were enrolled in the study.
Our definition of adverse event does not differ from the clinicaltrials.gov definition.
4.5%
1/22 • Patients were monitored for adverse events for the 6 month duration that they were enrolled in the study.
Our definition of adverse event does not differ from the clinicaltrials.gov definition.
Nervous system disorders
Shingles
0.00%
0/19 • Patients were monitored for adverse events for the 6 month duration that they were enrolled in the study.
Our definition of adverse event does not differ from the clinicaltrials.gov definition.
4.5%
1/22 • Patients were monitored for adverse events for the 6 month duration that they were enrolled in the study.
Our definition of adverse event does not differ from the clinicaltrials.gov definition.

Other adverse events

Other adverse events
Measure
Control Group
n=19 participants at risk
This group receives no experimental bracing intervention in the study.
Experimental Group
n=22 participants at risk
Breg Fusion Osteoarthritis knee unloading brace Fusion OA Knee Brace: This group is assigned to wear an unloading brace and report pain and quality of life by completion of a pain diary and related questionnaires.
Skin and subcutaneous tissue disorders
Rash
15.8%
3/19 • Number of events 3 • Patients were monitored for adverse events for the 6 month duration that they were enrolled in the study.
Our definition of adverse event does not differ from the clinicaltrials.gov definition.
9.1%
2/22 • Number of events 2 • Patients were monitored for adverse events for the 6 month duration that they were enrolled in the study.
Our definition of adverse event does not differ from the clinicaltrials.gov definition.
Injury, poisoning and procedural complications
Fall
0.00%
0/19 • Patients were monitored for adverse events for the 6 month duration that they were enrolled in the study.
Our definition of adverse event does not differ from the clinicaltrials.gov definition.
4.5%
1/22 • Number of events 1 • Patients were monitored for adverse events for the 6 month duration that they were enrolled in the study.
Our definition of adverse event does not differ from the clinicaltrials.gov definition.

Additional Information

Dr. Roger Ostrander

Andrews Institute for Orthopaedics & Sports Medicine

Phone: 850-916-3700

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place